Related Experiment Video

Updated: Sep 20, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function

Eric L Snyder1, Bryan R Meade, Steven F Dowdy

  • 1Howard Hughes Medical Institute and Department of Cellular and Molecular Medicine, UCSD School of Medicine, La Jolla, CA 92093-0686, USA.

Journal of Controlled Release : Official Journal of the Controlled Release Society
|August 23, 2003
PubMed

Insights

Researchers developed a protein delivery method to target cancer cells. This strategy successfully delivered the p27(Kip) tumor suppressor protein in mouse models, offering a new approach for cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Understanding oncogenesis relies on identifying tumor suppressor genes.
  • Developing targeted anti-cancer therapies requires effective delivery of therapeutic proteins.
  • Large tumor suppressor proteins face delivery challenges in vivo due to their size.

Purpose of the Study:

  • To demonstrate the efficacy of protein transduction for delivering tumor suppressor proteins in vivo.
  • To utilize the TAT protein transduction domain for enhanced protein delivery.
  • To explore novel anti-cancer strategies targeting tumor biology.

Main Methods:

  • Generation of an N-terminal fusion protein incorporating the TAT protein transduction domain.
  • Application of protein transduction for delivering the p27(Kip) tumor suppressor protein.
  • Testing the strategy in several established mouse tumor models.

Main Results:

  • Successful delivery of biologically active proteins (>100,000 Da) into cells and tissues.
  • Demonstrated manipulation of tumor biology in vivo using delivered p27(Kip).
  • Achieved delivery into approximately 100% of cells in culture and most cells/tissues in mouse models.

Conclusions:

  • Protein transduction is a viable strategy for delivering large therapeutic proteins in vivo.
  • This method enables the manipulation of tumor suppressor proteins for potential cancer treatment.
  • Further development of peptide and protein delivery holds promise for treating malignancies.

More Related Videos

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...